2002
DOI: 10.1021/bp0200447
|View full text |Cite
|
Sign up to set email alerts
|

Targeting Systemically Administered Proteins to Bone by Bisphosphonate Conjugation

Abstract: To develop a methodology for bone-specific delivery of proteins, a bone-seeking aminobisphosphonate (aminoBP) was previously conjugated to a model protein, bovine serum albumin (BSA). The conjugates were shown to exhibit a high affinity to bone in vitro and in vivo. This study was conducted to determine whether the systemic delivery of proteins to bone can be increased by aminoBP conjugation. Two model proteins used for this study were BSA and lysozyme (LYZ). For each protein, an unmodified (i.e., control) and… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

5
62
1
1

Year Published

2004
2004
2017
2017

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 64 publications
(69 citation statements)
references
References 28 publications
5
62
1
1
Order By: Relevance
“…19 For bone targeting purposes, conjugates with ϳ 11 aminoBP/BSA were capable of seeking bone tissue after systemic administration due to their inherent affinity to the bone mineral hydroxyapatite. 6 Accordingly, the reaction conditions utilizing the SPDP and thiolBP were able to yield the necessary extent of BP substitution on the target protein.…”
Section: Control Of Bp Conjugation To Bsamentioning
confidence: 99%
See 1 more Smart Citation
“…19 For bone targeting purposes, conjugates with ϳ 11 aminoBP/BSA were capable of seeking bone tissue after systemic administration due to their inherent affinity to the bone mineral hydroxyapatite. 6 Accordingly, the reaction conditions utilizing the SPDP and thiolBP were able to yield the necessary extent of BP substitution on the target protein.…”
Section: Control Of Bp Conjugation To Bsamentioning
confidence: 99%
“…The feasibility of this approach has been shown by conjugating BPs to several proteins, including albumin, 5 lysozyme, 6 nonspecific IgG, 7 and fetuin, 8 which were all shown to exhibit increased hydroxyapatite binding upon BP conjugation. The fetuin-BP conjugates were recently shown to exhibit an increased mineral affinity in vivo when they were implanted subcutaneously by using coralline apatite Pro-Osteon™ implants that are used for spinal surgery.…”
Section: Contract Grant Sponsor: Canadian Health Institutes Of Researmentioning
confidence: 99%
“…Entretanto, a afinidade aos ossos não foi comprovada 43 . Uludag e colaboradores 44 , utilizando albumina sérica bovina (ASB) como proteína modelo, demonstraram in vitro que a afinidade da proteína modificada é diretamente proporcional à extensão de conjugação (5 BFs por proteína). O conjugado aminoBF (BF-ASB) mostrou ter alta afinidade óssea in vivo após injeção intra-óssea (tí-bia) em ratos 30 .…”
Section: Proteínas Dirigidas Aos Ossosunclassified
“…The initiator used was succinimide-derivatized 4,4'-azobis(4-cyanovaleric acid), whose decomposition kinetics was similar to parent azo-compound: t 1/2 : 231 and 247 minutes, respectively, at 70 0 C in DMF [26]. To synthesize the initiator, 3 g (10.7 mmol) of 4,4'-azobis(4-cyanovaleric acid) and 2.5 g (21 mmol) NHS were dissolved in 50 mL anhydrous DMF.…”
Section: Synthesis and Characterization Of Random (Rp) And Comb Polymmentioning
confidence: 99%